Mannkind Corp Stock Buy Hold or Sell Recommendation
| MNKD Stock | USD 6.72 0.12 1.75% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding MannKind Corp is 'Strong Buy'. Macroaxis provides MannKind Corp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MNKD positions.
Check out MannKind Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide. Note, we conduct extensive research on individual companies such as MannKind and provide practical buy, sell, or hold advice based on investors' constraints. MannKind Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
MannKind |
Execute MannKind Corp Buy or Sell Advice
The MannKind recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MannKind Corp. Macroaxis does not own or have any residual interests in MannKind Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MannKind Corp's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | OK | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
MannKind Corp Trading Alerts and Improvement Suggestions
| MannKind Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 198.96 M. Net Loss for the year was (11.94 M) with profit before overhead, payroll, taxes, and interest of 42.27 M. | |
| MannKind Corp has a frail financial position based on the latest SEC disclosures | |
| About 57.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Connor Clark Lunn Investment Management Ltd. Buys 251,587 Shares of MannKind Co. - MarketBeat |
MannKind Corp Returns Distribution Density
The distribution of MannKind Corp's historical returns is an attempt to chart the uncertainty of MannKind Corp's future price movements. The chart of the probability distribution of MannKind Corp daily returns describes the distribution of returns around its average expected value. We use MannKind Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MannKind Corp returns is essential to provide solid investment advice for MannKind Corp.
| Mean Return | 0.36 | Value At Risk | -2.26 | Potential Upside | 4.28 | Standard Deviation | 2.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MannKind Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MannKind Stock Institutional Investors
| Shares | Northern Trust Corp | 2024-09-30 | 2.6 M | Tsp Capital Management Group/llc | 2024-09-30 | 2.5 M | Nuveen Asset Management, Llc | 2024-06-30 | 2.4 M | Parkman Healthcare Partners Llc | 2024-06-30 | 2.4 M | Charles Schwab Investment Management Inc | 2024-09-30 | 2.2 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 2.1 M | 180 Wealth Advisors, Llc | 2024-09-30 | 2.1 M | Eversept Partners, Llc | 2024-09-30 | 2 M | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 1.9 M | Blackrock Inc | 2024-06-30 | 22.6 M | Vanguard Group Inc | 2024-09-30 | 15.6 M |
MannKind Corp Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (41.5M) | 36.9M | 57.0M | (54.4M) | 168.7M | 177.1M | |
| Free Cash Flow | (91.0M) | (32.9M) | (73.2M) | (88.3M) | (8.3M) | (8.8M) | |
| Depreciation | 2.2M | 3.3M | 5.5M | 9.1M | 5.8M | 7.4M | |
| Other Non Cash Items | (28.0M) | 18.4M | 6.6M | 8.2M | 7.9M | 5.1M | |
| Capital Expenditures | 2.6M | 4.8M | 11.5M | 7.6M | 42.4M | 44.6M | |
| Net Income | (51.9M) | (57.2M) | (80.9M) | (87.4M) | (11.9M) | (12.5M) | |
| End Period Cash Flow | 30.2M | 67.2M | 124.2M | 69.8M | 238.5M | 250.4M | |
| Change To Inventory | (558K) | (1.3M) | (4.1M) | (5.7M) | 4.6M | 4.8M | |
| Investments | (20.3M) | 20M | (137.1M) | 4.9M | 20.9M | 22.0M | |
| Net Borrowings | 63.7M | 14.9M | 177.7M | (18K) | (20.7K) | (19.7K) | |
| Change To Netincome | 868K | 30.4M | 24.8M | 10.9M | 9.8M | 17.4M | |
| Change Receivables | 504K | (705K) | (776K) | (11.8M) | (13.6M) | (12.9M) |
MannKind Corp Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MannKind Corp or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MannKind Corp's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MannKind stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 1.90 | |
Ir | Information ratio | 0.11 |
MannKind Corp Volatility Alert
MannKind Corp has relatively low volatility with skewness of 1.65 and kurtosis of 4.82. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MannKind Corp's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MannKind Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MannKind Corp Fundamentals Vs Peers
Comparing MannKind Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MannKind Corp's direct or indirect competition across all of the common fundamentals between MannKind Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as MannKind Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MannKind Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MannKind Corp to competition |
| Fundamentals | MannKind Corp | Peer Average |
| Return On Asset | 0.0912 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.22 % | (5.51) % |
| Current Valuation | 1.84 B | 16.62 B |
| Shares Outstanding | 275.78 M | 571.82 M |
| Shares Owned By Insiders | 1.83 % | 10.09 % |
| Shares Owned By Institutions | 56.60 % | 39.21 % |
| Number Of Shares Shorted | 42.87 M | 4.71 M |
| Price To Earning | 2.27 X | 28.72 X |
| Price To Sales | 6.94 X | 11.42 X |
| Revenue | 198.96 M | 9.43 B |
| Gross Profit | 42.27 M | 27.38 B |
| EBITDA | 15.13 M | 3.9 B |
| Net Income | (11.94 M) | 570.98 M |
| Cash And Equivalents | 154.16 M | 2.7 B |
| Cash Per Share | 0.60 X | 5.01 X |
| Total Debt | 382.38 M | 5.32 B |
| Debt To Equity | 9.93 % | 48.70 % |
| Current Ratio | 3.25 X | 2.16 X |
| Book Value Per Share | (0.76) X | 1.93 K |
| Cash Flow From Operations | 34.09 M | 971.22 M |
| Short Ratio | 23.04 X | 4.00 X |
| Earnings Per Share | 0.08 X | 3.12 X |
| Price To Earnings To Growth | (0.23) X | 4.89 X |
| Target Price | 9.25 | |
| Number Of Employees | 411 | 18.84 K |
| Beta | 1.3 | -0.15 |
| Market Capitalization | 1.85 B | 19.03 B |
| Total Asset | 475.2 M | 29.47 B |
| Retained Earnings | (3.23 B) | 9.33 B |
| Working Capital | 269.27 M | 1.48 B |
| Current Asset | 76.65 M | 9.34 B |
| Current Liabilities | 268.32 M | 7.9 B |
Note: Disposition of 22513 shares by Steven Binder of MannKind Corp at 1.47 subject to Rule 16b-3 [view details]
MannKind Corp Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MannKind . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MannKind Corp Buy or Sell Advice
When is the right time to buy or sell MannKind Corp? Buying financial instruments such as MannKind Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MannKind Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out MannKind Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade MannKind Stock refer to our How to Trade MannKind Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MannKind Corp. If investors know MannKind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MannKind Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.246 | Earnings Share 0.08 | Revenue Per Share 0.982 | Quarterly Revenue Growth 0.367 | Return On Assets 0.0912 |
The market value of MannKind Corp is measured differently than its book value, which is the value of MannKind that is recorded on the company's balance sheet. Investors also form their own opinion of MannKind Corp's value that differs from its market value or its book value, called intrinsic value, which is MannKind Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MannKind Corp's market value can be influenced by many factors that don't directly affect MannKind Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MannKind Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if MannKind Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MannKind Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.